Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 250

Similar articles for PubMed (Select 24780727)

1.

Differential proteomic approach for identification and verification of aberrantly glycosylated proteins in adenocarcinoma lung cancer (ADLC) plasmas by lectin-capturing and targeted mass spectrometry.

Ahn YH, Ji ES, Oh NR, Kim YS, Ko JH, Yoo JS.

J Proteomics. 2014 Jun 25;106:221-9. doi: 10.1016/j.jprot.2014.04.031. Epub 2014 Apr 26.

PMID:
24780727
2.

Quantitative analysis of aberrant protein glycosylation in liver cancer plasma by AAL-enrichment and MRM mass spectrometry.

Ahn YH, Shin PM, Kim YS, Oh NR, Ji ES, Kim KH, Lee YJ, Kim SH, Yoo JS.

Analyst. 2013 Nov 7;138(21):6454-62. doi: 10.1039/c3an01126g.

PMID:
24027776
3.

A lectin-coupled, targeted proteomic mass spectrometry (MRM MS) platform for identification of multiple liver cancer biomarkers in human plasma.

Ahn YH, Shin PM, Oh NR, Park GW, Kim H, Yoo JS.

J Proteomics. 2012 Sep 18;75(17):5507-15. doi: 10.1016/j.jprot.2012.06.027. Epub 2012 Jul 10.

PMID:
22789673
4.

A lectin-coupled, multiple reaction monitoring based quantitative analysis of human plasma glycoproteins by mass spectrometry.

Ahn YH, Shin PM, Ji ES, Kim H, Yoo JS.

Anal Bioanal Chem. 2012 Feb;402(6):2101-12. doi: 10.1007/s00216-011-5646-3.

PMID:
22290386
5.

A multiplex lectin-channel monitoring method for human serum glycoproteins by quantitative mass spectrometry.

Ahn YH, Ji ES, Shin PM, Kim KH, Kim YS, Ko JH, Yoo JS.

Analyst. 2012 Feb 7;137(3):691-703. doi: 10.1039/c1an15775b. Epub 2011 Dec 8.

PMID:
22158852
6.

Comparative quantitation of aberrant glycoforms by lectin-based glycoprotein enrichment coupled with multiple-reaction monitoring mass spectrometry.

Ahn YH, Kim YS, Ji ES, Lee JY, Jung JA, Ko JH, Yoo JS.

Anal Chem. 2010 Jun 1;82(11):4441-7. doi: 10.1021/ac1001965.

PMID:
20462175
7.

Glycoproteomics approach for identifying Glycobiomarker candidate molecules for tissue type classification of non-small cell lung carcinoma.

Hirao Y, Matsuzaki H, Iwaki J, Kuno A, Kaji H, Ohkura T, Togayachi A, Abe M, Nomura M, Noguchi M, Ikehara Y, Narimatsu H.

J Proteome Res. 2014 Nov 7;13(11):4705-16. doi: 10.1021/pr5006668. Epub 2014 Sep 22.

PMID:
25244057
8.
9.

Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS.

Wu J, Xie X, Liu Y, He J, Benitez R, Buckanovich RJ, Lubman DM.

J Proteome Res. 2012 Sep 7;11(9):4541-52. doi: 10.1021/pr300330z. Epub 2012 Aug 6.

PMID:
22827608
10.

Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer.

Ahn JM, Sung HJ, Yoon YH, Kim BG, Yang WS, Lee C, Park HM, Kim BJ, Kim BG, Lee SY, An HJ, Cho JY.

Mol Cell Proteomics. 2014 Jan;13(1):30-48. doi: 10.1074/mcp.M113.028621. Epub 2013 Oct 1.

11.

Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry.

Zeng X, Hood BL, Sun M, Conrads TP, Day RS, Weissfeld JL, Siegfried JM, Bigbee WL.

J Proteome Res. 2010 Dec 3;9(12):6440-9. doi: 10.1021/pr100696n. Epub 2010 Oct 28.

12.

Targeted serum glycoproteomics for the discovery of lung cancer-associated glycosylation disorders using lectin-coupled ProteinChip arrays.

Ueda K, Fukase Y, Katagiri T, Ishikawa N, Irie S, Sato TA, Ito H, Nakayama H, Miyagi Y, Tsuchiya E, Kohno N, Shiwa M, Nakamura Y, Daigo Y.

Proteomics. 2009 Apr;9(8):2182-92. doi: 10.1002/pmic.200800374.

PMID:
19322776
13.

MRM validation of targeted nonglycosylated peptides from N-glycoprotein biomarkers using direct trypsin digestion of undepleted human plasma.

Lee JY, Kim JY, Cheon MH, Park GW, Ahn YH, Moon MH, Yoo JS.

J Proteomics. 2014 Feb 26;98:206-17. doi: 10.1016/j.jprot.2014.01.003. Epub 2014 Jan 14.

PMID:
24434586
14.

Analysis of glycan variation on glycoproteins from serum by the reverse lectin-based ELISA assay.

Wu J, Zhu J, Yin H, Buckanovich RJ, Lubman DM.

J Proteome Res. 2014 Apr 4;13(4):2197-204. doi: 10.1021/pr401061c. Epub 2014 Mar 10.

15.

A lectin affinity workflow targeting glycosite-specific, cancer-related carbohydrate structures in trypsin-digested human plasma.

Drake PM, Schilling B, Niles RK, Braten M, Johansen E, Liu H, Lerch M, Sorensen DJ, Li B, Allen S, Hall SC, Witkowska HE, Regnier FE, Gibson BW, Fisher SJ.

Anal Biochem. 2011 Jan 1;408(1):71-85. doi: 10.1016/j.ab.2010.08.010. Epub 2010 Aug 10.

16.

Elucidation of N-glycosites within human plasma glycoproteins for cancer biomarker discovery.

Drake P, Schilling B, Gibson B, Fisher S.

Methods Mol Biol. 2013;951:307-22. doi: 10.1007/978-1-62703-146-2_21.

PMID:
23296540
17.

Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot.

Qiu Y, Patwa TH, Xu L, Shedden K, Misek DE, Tuck M, Jin G, Ruffin MT, Turgeon DK, Synal S, Bresalier R, Marcon N, Brenner DE, Lubman DM.

J Proteome Res. 2008 Apr;7(4):1693-703. doi: 10.1021/pr700706s. Epub 2008 Feb 27.

18.

Development of an AlphaLISA assay to quantify serum core-fucosylated E-cadherin as a metastatic lung adenocarcinoma biomarker.

Wen CL, Chen KY, Chen CT, Chuang JG, Yang PC, Chow LP.

J Proteomics. 2012 Jul 16;75(13):3963-76. doi: 10.1016/j.jprot.2012.05.015. Epub 2012 May 23.

PMID:
22634079
19.
20.

Identification of low-abundance cancer biomarker candidate TIMP1 from serum with lectin fractionation and peptide affinity enrichment by ultrahigh-resolution mass spectrometry.

Ahn YH, Kim KH, Shin PM, Ji ES, Kim H, Yoo JS.

Anal Chem. 2012 Feb 7;84(3):1425-31. doi: 10.1021/ac2024987. Epub 2012 Jan 13.

PMID:
22196688
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk